Stockscreener 앱 받기
1.08
0.92%
-0.01
시간 외 거래:
1.09
0.01
+0.93%
전일 마감가:
$1.09
열려 있는:
$1.08
하루 거래량:
88,103
Relative Volume:
0.22
시가총액:
$256.37M
수익:
-
순이익/손실:
$-12.70M
주가수익비율:
-2.0217
EPS:
-0.5342
순현금흐름:
$-12.36M
1주 성능:
+0.93%
1개월 성능:
+2.86%
6개월 성능:
+3.35%
1년 성능:
-3.57%
1일 변동 폭
$1.0601
$1.09
1주일 범위
$1.0301
$1.14
52주 변동 폭
$0.66
$2.10
엔라이벡스 Stock (ENLV) Company Profile
Compare ENLV vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENLV
Enlivex Ltd
|
1.08 | 258.75M | 0 | -12.70M | -12.36M | -0.5342 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
엔라이벡스 Stock (ENLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-02 | 재확인 | H.C. Wainwright | Buy |
엔라이벡스 주식(ENLV)의 최신 뉴스
EBIT per share of Enlivex Ltd. – LS:A119KH - TradingView
Sentiment Recap: How does Enlivex Therapeutics Ltd score in quality rankings2026 Spike Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Nasdaq Moves: Can Enlivex Therapeutics Ltd reach all time highs this year - baoquankhu1.vn
[Form 3] Enlivex Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Enlivex (ENLV) CFO discloses initial share and option holdings - Stock Titan
Enlivex (ENLV) director Hart Gili reports option and share holdings - Stock Titan
Enlivex (ENLV) director discloses major share and option stake - Stock Titan
Enlivex (NASDAQ: ENLV) director discloses share and option stake - Stock Titan
Enlivex (ENLV) CMO discloses initial share and stock option holdings - Stock Titan
Published on: 2026-03-17 18:55:28 - baoquankhu1.vn
Operating cash flow per share of Enlivex Ltd. – SWB:1BT - TradingView
Enlivex Therapeutics Ltd expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ENLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Palm Beach Daily News
Enlivex Therapeutics (NASDAQ:ENLV) Rating Increased to Hold at Wall Street Zen - Defense World
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | 1BT | IL0011319527 - marketscreener.com
1BT: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Dividend historical data and projections - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | 1BT | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, 1BT Stock Price on Börse Stuttgart Exchange - marketscreener.com
Enlivex Ltd.: Target Price Consensus and Analysts Recommendations | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Revenue and Earnings Analysts Forecasts Revisions | ENLV | IL0011319527 - marketscreener.com
Enlivex Ltd.: Shareholders Board Members Managers and Company Profile | IL0011319527 - marketscreener.com
Enlivex (ENLV) Stock Analysis Report | Financials & Insights - Benzinga Japan
Enlivex Ltd.: Financial Data Forecasts Estimates and Expectations | ENLV | IL0011319527 - marketscreener.com
ENLV: Static price chart | Enlivex Ltd. | IL0011319527 - marketscreener.com
Enlivex Ltd.: Performance & Quotes, ENLV Stock Price on Nasdaq Exchange - marketscreener.com
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval - The Globe and Mail
Aug Closing: Is Enlivex Therapeutics Ltd forming a bullish divergenceIndex Update & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Enlivex (ENLV) shareholders approve and complete corporate name change - Stock Titan
Enlivex Therapeutics (ENLV) to Release Quarterly Earnings on Wednesday - Defense World
Can Enlivex Therapeutics Ltd. reach all time highs this yearJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - mfd.ru
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Drivers: Is QVCGB stock overvalued or fairly pricedWeekly Gains Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
ENLV to Participate in Virtual Meeting Hosted by BTIG - GuruFocus
Will Enlivex Therapeutics Ltd. stock benefit from infrastructure spendingForecast Cut & Short-Term High Return Ideas - mfd.ru
Enlivex Therapeutics (NASDAQ:ENLV) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Volatile Outlook for Enlivex Therapeutics as Investors Await Clinical Catalysts - Born2Invest
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update - MarketBeat
Enlivex Therapeutics announces new listing of RAIN token on Kraken - Yahoo Finance
Activity Recap: What are Enlivex Therapeutics Ltd.’s growth leversBear Alert & Free Verified High Yield Trade Plans - mfd.ru
Will Enlivex Therapeutics Ltd. outperform its industry peers2025 Investor Takeaways & Technical Pattern Based Signals - mfd.ru
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy - MSN
Enlivex Therapeutics (ENLV) Expands RAIN Token Accessibility wit - GuruFocus
Enlivex’s RAIN Treasury Token Debuts on Kraken to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange - The Manila Times
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Asheville Citizen Times
Enlivex Shareholders Approve Amended Articles of Association at February 3 Meeting - The Globe and Mail
Enlivex Completes Private Placement to Fund Digital Asset Strategy - MSN
엔라이벡스 (ENLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):